ReviewThe EPMA journal2025
Repurposing holistic effects of metformin from diabetes management to skin wound healing: a 3PM-guided innovation.
Review in The EPMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metformin has recently garnered attention for its unique role in cellular metabolism regulation, prompting investigations into its potential applications in skin wound healing. Predictive, preventive, and personalized medicine (PPPM/3PM) is the most advantageous healthcare framework and is appropriate for managing chronic illnesses. This review systematically outlines the key signaling pathways through which metformin modulates inflammatory responses via metabolic reprogramming. Integrating the 3PM concept, it explores innovative application strategies for metformin in wound management, thereby proposing a working hypothesis: metformin may be utilized for personalized prevention and treatment of skin wounds. It focuses on the latest research advances in the field of wound healing, particularly the potential of metformin in local applications, as well as studies combining it with innovative carriers such as hydrogels, nanofibers, and microneedles. These studies not only expand the therapeutic scope of metformin but also provide novel perspectives and solutions to the management of chronic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.